Wuhan Hualianke Biotechnology Co., Ltd.

Wuhan Hualianke Biotechnology Co., Ltd. (华联科生物) is a Chinese biotechnology company founded in 2014 and headquartered in Wuhan, Hubei Province. The company positions itself as an integrated supplier of animal models, serving hospitals, universities, research institutes and pharmaceutical researchers across China. Its core focus is the research, development and application of complex disease models, a niche that sits at the intersection of laboratory animal science, disease biology and preclinical research services. Hualianke's business spans six main areas: commercial induced disease animal models; commercial spontaneous (origin) disease animal models; production and sale of SPF-grade wild mice (background mice); production and application of germ-free mice; R&D and sale of animal feed and bedding; and shared animal facility services. Its product catalog covers disease models across the respiratory, nervous, digestive, cardiovascular and cerebrovascular, orthopedic, urinary, reproductive, oncological, metabolic (endocrine) and dermatological systems. It also supplies live animals including C57BL/6J, BALB/c, BALB/cA-nu, SCID, ICR and KM mice, SD rats, and conventional guinea pigs and rabbits, alongside feed and bedding. According to its official website, the company has a core team of more than 100 high-tech professionals, infrastructure of approximately 10,000 m², and testing equipment valued at over 20 million RMB. It operates animal facilities of more than 4,000 m² and reports more than 150 core professional team members in one site metric. Hualianke has been recognized as a Hubei Province "specialized, refined, distinctive and innovative" (专精特新) enterprise, a technology "little giant" enterprise, and an Optics Valley Gazelle enterprise. It has established industry-academia-research collaborations with multiple hospitals and universities, runs a dedicated laboratory animal model program jointly with Huazhong Agricultural University, and has set up the "Hualianke Biology - Innovation and Entrepreneurship Fund" at Hubei University of Chinese Medicine. The company reports more than 250 SCI papers published under its name, 86 approved patents, a first prize for scientific and technological progress from the China Pharmaceutical Association, and a second prize for scientific and technological progress from Hubei Province. Founder and chairman Huang Xianghong has been recognized under the Optics Valley 3351 Talent program. The company remains privately held and active, with its official website at hlkbio.cn serving as its primary commercial and informational channel.

Wuhan Hualianke Biotechnology Co., Ltd. was established in April 2014 in Wuhan, Hubei Province, China. The company was founded with a focus on the research, development and application of complex disease models, a specialized area within the broader life sciences and preclinical research sector. Its founder and chairman, Huang Xianghong, has been recognized under the Optics Valley 3351 Talent program and has authored SCI papers. From its founding, Hualianke built its business around the supply of laboratory animals and disease models to Chinese research institutions. Over the years it expanded its offerings from basic live animals and background mice to a broad catalog of induced and spontaneous disease models spanning multiple organ systems, as well as germ-free mice, animal feed and bedding, and shared animal facility services. The company reports that it has grown to a core team of more than 100 high-tech professionals, with infrastructure of approximately 10,000 m² and testing equipment valued at over 20 million RMB, including animal facilities of more than 4,000 m². Hualianke has pursued industry-academia-research collaboration as a core part of its development. It has partnered with hospitals and universities across China, established a dedicated laboratory animal model program jointly with Huazhong Agricultural University, and set up the "Hualianke Biology - Innovation and Entrepreneurship Fund" at Hubei University of Chinese Medicine. The company has been recognized as a Hubei Province specialized, refined, distinctive and innovative (专精特新) enterprise, a technology "little giant" enterprise, and an Optics Valley Gazelle enterprise. It reports more than 250 SCI papers published under its name and 86 approved patents, and has received a first prize for scientific and technological progress from the China Pharmaceutical Association and a second prize for scientific and technological progress from Hubei Province. The company's official website lists a development timeline beginning in 2014, the year of its founding, and continuing through subsequent years, reflecting its ongoing growth and expansion of capabilities. Hualianke remains an active, privately held enterprise headquartered in Wuhan.

• 2014

  Wuhan Hualianke Biotechnology Co., Ltd. was founded in April in Wuhan, China.

• Recognized as a Hubei Province specialized, refined, distinctive and innovative (专精特新) enterprise.

• Recognized as a technology "little giant" enterprise and an Optics Valley Gazelle enterprise.

• Established a joint laboratory animal model program with Huazhong Agricultural University.

• Set up the "Hualianke Biology - Innovation and Entrepreneurship Fund" at Hubei University of Chinese Medicine.

• Awarded first prize for scientific and technological progress by the China Pharmaceutical Association and second prize by Hubei Province.

Integrated supplier of animal models and preclinical research services for hospitals, universities and research institutes in China.

• Induced disease animal models

  Commercial chemically or physically induced models of human diseases.

• Spontaneous (origin) disease animal models

  Commercial models that develop disease spontaneously due to genetic background.

• SPF-grade wild mice (background mice)

  Specific-pathogen-free wild-type mice for research use.

• Germ-free mice

  Germ-free mice for microbiome and related research.

• Animal feed and bedding

  R&D and sale of feed and bedding for laboratory animals.

• Respiratory system models

  Includes OVA-induced allergic asthma and pulmonary fibrosis models in rats/mice.

• Nervous system models

  Disease models of the nervous system.

• Digestive system models

  Disease models of the digestive system.

• Cardiovascular and cerebrovascular system models

  Disease models of the cardiovascular and cerebrovascular systems.

• Orthopedic system models

  Disease models of the orthopedic system.

• Urinary system models

  Disease models of the urinary system.

• Reproductive system models

  Disease models of the reproductive system.

• Oncology-related models

  Cancer-related disease models.

• Metabolic (endocrine) system models

  Disease models of metabolic and endocrine systems.

• Dermatological system models

  Disease models of the skin.

• Live animals

  C57BL/6J, SD rats, BALB/c, BALB/cA-nu, SCID, ICR, KM, conventional guinea pigs, conventional rabbits.

• Animal experiment and testing services

  Technical services including animal experiments and testing across animal, cell, molecular and pathology platforms.

• Shared animal facility services

  Sharing and servicing of animal facilities.

1. 1华联科官网首页hlkbio.cn
2. 2华联科关于我们hlkbio.cn
3. 3华联科产品中心-动物模型hlkbio.cn
4. 4华联科产品中心-活体动物及配套产品hlkbio.cn
5. 5Wikidata: Wuhan Myhalic Biotechnological Co., Ltd (China)wikidata.org